Context TherapeuticsCNTX
13F holders, Q4 2025 (December 31)At the end of Q4 2025, 43 institutions reported holding Context Therapeutics Inc. (CNTX) in their 13F filings, up 6 from Q3 2025. 8 opened new positions and 4 sold out. The largest holders were MPM Bioimpact LLC ($15.7M), Blue Owl Capital Holdings LP ($10.9M) and Nextech Invest Ltd. ($10.9M). 4 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio), Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Steve Cohen (0.0% of Point72 Asset Management's portfolio).
- Company
- Context Therapeutics Inc.
- CUSIP
- 21077P108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $4.1M |
| Exits | 4 | $491K |
All 13F filers, Q3 2025 → Q4 2025: 5,940,533 shares bought and 9,711,419 shares sold, net −3,770,886 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 43 holders
| MPM Bioimpact LLC | 1.80% | Reduce -27.4% | 10,679,391 | $15.7M |
| Blue Owl Capital Holdings LP | 3.40% | Add +0.3% | 7,432,906 | $10.9M |
| Nextech Invest Ltd. | 1.05% | No change | 7,419,355 | $10.9M |
| Deep Track Capital, LP | 0.25% | No change | 7,419,355 | $10.9M |
| Avidity Partners Management LP | 2.33% | Reduce -38.7% | 5,504,855 | $8.1M |
| Great Point Partners LLC | 2.23% | No change | 4,683,711 | $6.9M |
| Franklin Resources Inc. | 0.00% | No change | 4,003,380 | $5.9M |
| Vanguard Group Inc. | 0.00% | Add +8.3% | 3,785,909 | $5.6M |
| Millennium Management | 0.00% | New | 2,601,216 | $3.8M |
| Marshall Wace, LLP | 0.00% | Add +7153.7% | 2,593,198 | $3.8M |
| Blackstone Inc. | 0.02% | No change | 2,440,330 | $3.6M |
| Alyeska Investment Group, L.P. | 0.01% | No change | 1,663,355 | $2.4M |
| Sio Capital Management, LLC | 0.33% | No change | 1,341,636 | $2.0M |
| BlackRock, Inc. | 0.00% | Reduce -0.1% | 848,046 | $1.2M |
| Geode Capital Management, LLC | 0.00% | Reduce -0.0% | 608,462 | $895K |
| Renaissance Technologies | 0.00% | Add +58.8% | 508,329 | $747K |
| ADAR1 Capital Management, LLC | 0.04% | No change | 351,094 | $516K |
| State Street Corp. | 0.00% | Add +8.5% | 165,607 | $243K |
| Walleye Capital LLC | 0.00% | No change | 132,786 | $195K |
| HighTower Advisors, LLC | 0.00% | No change | 125,852 | $185K |
| Pathstone Holdings, LLC | 0.00% | No change | 110,244 | $162K |
| Mill Creek Capital Advisors, LLC | 0.00% | No change | 104,631 | $154K |
| XTX Topco Ltd | 0.00% | Add +858.8% | 101,605 | $149K |
| Velan Capital Investment Management LP | 0.09% | No change | 100,000 | $147K |
| Deeter Investments LLP | 0.03% | — | 100,000 | $147K |
| Clear Harbor Asset Management, LLC | 0.01% | No change | 92,804 | $136K |
| Northern Trust Corp. | 0.00% | Add +27.0% | 84,281 | $124K |
| Point72 Asset Management | 0.00% | New | 52,701 | $77K |
| Quadrature Capital Ltd | 0.00% | New | 46,220 | $68K |
| Nantahala Capital Management, LLC | 0.00% | Reduce -97.7% | 37,837 | $56K |
| Citadel Advisors | 0.00% | Reduce -66.7% | 34,380 | $51K |
| Virtu Financial LLC | 0.00% | New | 28,921 | $43K |
| Osaic Holdings, Inc. | 0.00% | No change | 25,500 | $37K |
| Cerity Partners LLC | 0.00% | No change | 20,000 | $29K |
| Caxton Corp. | 0.63% | No change | 18,403 | $27K |
| Corient Private Wealth LP | 0.00% | New | 15,084 | $22K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 9,611 | $14K |
| Strive Financial Group ,LLC | 0.00% | — | 1,700 | $2K |
| Farther Finance Advisors, LLC | 0.00% | New | 1,500 | $2K |
| Citigroup Inc. | 0.00% | New | 1,348 | $2K |
| Bank of America Corp. | 0.00% | Add +115.0% | 933 | $1K |
| UBS Group AG | 0.00% | Reduce -93.4% | 490 | $720 |
| SBI Securities Co., Ltd. | 0.00% | Reduce -2.6% | 114 | $168 |
"% of holder's portfolio" is CNTX's weight in each manager's 13F, not the share of Context Therapeutics Inc. the manager owns.